CompletedPhase 2Phase 3ACTRN12606000331538

Effects of vitamin D and calcium on bone and falls in an elderly population of Australian women selected for their history of falling

A randomised controlled study to evaluate the effects of vitamin D and calcium on lowering fall risk and improving bone structure in an elderly population of Australian women with low vitamin D status and a history of falling

Sponsor

Australian National Health and Medical Research Council

Enrollment

294 participants

Start Date

Apr 1, 2003

Study Type

Interventional

Conditions

Falls and bone structure in elderly Australian women

Summary

This is a one-year randomised, double blind, placebo controlled study designed to evaluate the effects of ergocalciferol and calcium supplementation compared to calcium alone on fall risk and bone structure in elderly women with a plasma 25-hydroxy vitamin D level below 60 nmol/L and a history of falling in the past 12 months. Subjects were randomised by personnel having no contact with study subjects. The study subjects and the study staff remained blinded to the treatment codes during the 1 year study.

Eligibility

Sex: FemalesMin Age: 70 YearssMax Age: 90 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests whether vitamin D and calcium supplements can strengthen bones and reduce falls in women aged 70-90 who have a history of falling and low vitamin D levels. Participants must not already be taking bone medications or vitamin D supplements.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

A one-year randomised double-blind clinical trial of oral supplementation of 1000 International Units of ergocalciferol per day versus placebo. All subjects received 1000 mg of calcium per day orally

A one-year randomised double-blind clinical trial of oral supplementation of 1000 International Units of ergocalciferol per day versus placebo. All subjects received 1000 mg of calcium per day orally as calcium citrate.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000331538